Literature DB >> 20483774

The microtubule regulator stathmin is an endogenous protein agonist for TLR3.

Malika Bsibsi1, Jeffrey J Bajramovic, Mario H J Vogt, Eveline van Duijvenvoorden, Aabed Baghat, Carla Persoon-Deen, Frans Tielen, Richard Verbeek, Inge Huitinga, Bernhard Ryffel, Alexander Kros, Wouter H Gerritsen, Sandra Amor, Johannes M van Noort.   

Abstract

TLR3 recognizes dsRNAs and is considered of key importance to antiviral host-defense responses. TLR3 also triggers neuroprotective responses in astrocytes and controls the growth of axons and neuronal progenitor cells, suggesting additional roles for TLR3-mediated signaling in the CNS. This prompted us to search for alternative, CNS-borne protein agonists for TLR3. A genome-scale functional screening of a transcript library from brain tumors revealed that the microtubule regulator stathmin is an activator of TLR3-dependent signaling in astrocytes, inducing the same set of neuroprotective factors as the known TLR3 agonist polyinosinic:polycytidylic acid. This activity of stathmin crucially depends on a long, negatively charged alpha helix in the protein. Colocalization of stathmin with TLR3 on astrocytes, microglia, and neurons in multiple sclerosis-affected human brain indicates that as an endogenous TLR3 agonist, stathmin may fulfill previously unsuspected regulatory roles during inflammation and repair in the adult CNS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483774     DOI: 10.4049/jimmunol.0902419

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  SARM1, Not MyD88, Mediates TLR7/TLR9-Induced Apoptosis in Neurons.

Authors:  Piyali Mukherjee; Clayton W Winkler; Katherine G Taylor; Tyson A Woods; Vinod Nair; Burhan A Khan; Karin E Peterson
Journal:  J Immunol       Date:  2015-09-30       Impact factor: 5.422

Review 2.  The role of neuroimmune signaling in alcoholism.

Authors:  Fulton T Crews; Colleen J Lawrimore; T Jordan Walter; Leon G Coleman
Journal:  Neuropharmacology       Date:  2017-02-01       Impact factor: 5.250

Review 3.  Toll-like receptor signaling in neural plasticity and disease.

Authors:  Eitan Okun; Kathleen J Griffioen; Mark P Mattson
Journal:  Trends Neurosci       Date:  2011-03-16       Impact factor: 13.837

4.  Unexpected protective role for Toll-like receptor 3 in the arterial wall.

Authors:  Jennifer E Cole; Tina J Navin; Amanda J Cross; Michael E Goddard; Lena Alexopoulou; Anuja T Mitra; Alun H Davies; Richard A Flavell; Marc Feldmann; Claudia Monaco
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

Review 5.  The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies.

Authors:  Anna Warden; Emma Erickson; Gizelle Robinson; R Adron Harris; R Dayne Mayfield
Journal:  Pharmacogenomics       Date:  2016-12-05       Impact factor: 2.533

6.  Role of toll-like receptors in multiple sclerosis.

Authors:  Socorro Miranda-Hernandez; Alan G Baxter
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

7.  Innate Immune Signaling and Alcohol Use Disorders.

Authors:  Leon G Coleman; Fulton T Crews
Journal:  Handb Exp Pharmacol       Date:  2018

8.  Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains.

Authors:  Douglas G Walker; Tiffany M Tang; Lih-Fen Lue
Journal:  Exp Neurol       Date:  2018-08-01       Impact factor: 5.330

9.  Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis.

Authors:  Massimo Santoro; Viviana Nociti; Matteo Lucchini; Chiara De Fino; Francesco Antonio Losavio; Massimiliano Mirabella
Journal:  J Mol Neurosci       Date:  2016-03-31       Impact factor: 3.444

10.  Toll-like receptor 3 (TLR3) protects retinal pigmented epithelium (RPE) cells from oxidative stress through a STAT3-dependent mechanism.

Authors:  Amit K Patel; Abigail S Hackam
Journal:  Mol Immunol       Date:  2012-12-23       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.